FDA Law Blog: ACI’s Legal, Regulatory, & Compliance Forum on Controlled Substances

FDA Law Blog: ACI’s Legal, Regulatory, & Compliance Forum on Controlled Substances

ACI’s Legal, Regulatory, & Compliance Forum on Controlled Substances

Posted: 22 Oct 2017 09:56 AM PDT

The American Conference Institute’s Legal, Regulatory, & Compliance Forum on Controlled Substances is scheduled to take place in Washington, D.C. from January 29-31, 2018.

Esteemed, top-notch faculty speaking at the conference include current and former officials from the DEA and FDA, representatives from State Attorney General and U.S. Attorney Offices, as well as high-level in-house executives, and top outside counsel. Conference speakers will provide their insights into the most pressing topics affecting the space such as:

• Reassessing your Responsibilities in Light of the Changing Scope of Suspicious Order Monitoring Requirements
• Evolution of Abuse-Deterrent Opioid Drug Products
• Understanding and Comparing State Prescription Drug Monitoring Programs
• Diving into the State, County, and City Opioid-Related Investigations

Hyman, Phelps & McNamara, P.C.’s John A. Gilbert, Jr. will be speaking at a session titled “Overcoming Challenges for Schedule III Opioids and Non-Opioid Products,” and will be moderating a panel discussion, titled “Politics and Policy of Controlled Substances in View of the Opioid Overdose Crisis.”

FDA Law Blog is a conference media partner. As such, we can offer our readers a special 10% discount. The discount code is: P10-999-FDAB18. You can access the conference brochure and sign up for the event here. We look forward to seeing you at the conference.